Title |
Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway
|
---|---|
Published in |
Drug Design, Development and Therapy, March 2015
|
DOI | 10.2147/dddt.s74197 |
Pubmed ID | |
Authors |
Ning-Kui Niu, Zi-Li Wang, Shu-Ting Pan, Hui-Qiang Ding, Giang HT Au, Zhi-Xu He, Zhi-Wei Zhou, Guozhi Xiao, Yin-Xue Yang, Xueji Zhang, Tianxin Yang, Xiao-Wu Chen, Jia-Xuan Qiu, Shu-Feng Zhou |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 3% |
Unknown | 32 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 7 | 21% |
Student > Bachelor | 5 | 15% |
Student > Ph. D. Student | 4 | 12% |
Student > Doctoral Student | 3 | 9% |
Researcher | 3 | 9% |
Other | 8 | 24% |
Unknown | 3 | 9% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 10 | 30% |
Agricultural and Biological Sciences | 8 | 24% |
Medicine and Dentistry | 8 | 24% |
Immunology and Microbiology | 1 | 3% |
Psychology | 1 | 3% |
Other | 1 | 3% |
Unknown | 4 | 12% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 March 2024.
All research outputs
#8,046,266
of 25,605,018 outputs
Outputs from Drug Design, Development and Therapy
#550
of 2,271 outputs
Outputs of similar age
#85,533
of 271,522 outputs
Outputs of similar age from Drug Design, Development and Therapy
#22
of 69 outputs
Altmetric has tracked 25,605,018 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 2,271 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 271,522 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.